89bio所有資訊

89bio | 4：持股變動聲明-董事 Babler Martin

05/03 16:03 (美東)

89bio | 3：首次持股聲明-董事 Babler Martin

04/23 16:06 (美東)

89bio | 4：持股變動聲明-董事 RA CAPITAL MANAGEMENT, L.P.

04/15 16:20 (美東)

89bio | 4：持股變動聲明-高管 PALEKAR ROHAN

04/03 16:03 (美東)

89bio | SC 13D/A：超過5%持股股東披露文件(修正)-RA Capital Management, L.P.(14.8%),Peter Kolchinsky(14.8%)等

03/06 18:51 (美東)

89bio | 4：持股變動聲明-董事 RA CAPITAL MANAGEMENT, L.P.

03/06 17:46 (美東)

89bio | 4：持股變動聲明-高管 PALEKAR ROHAN

02/28 18:49 (美東)

89bio | 4：持股變動聲明-高管 Martins Ryan

02/23 21:01 (美東)

89bio | 4：持股變動聲明-高管 PALEKAR ROHAN

02/23 20:55 (美東)

89bio | 4：持股變動聲明-高管 Le-Nguyen Quoc

02/23 20:51 (美東)

89bio | 4：持股變動聲明-高管 Mansbach Harry H

02/23 20:45 (美東)

89bio | SC 13G/A：超過5%持股股東披露文件(修正)-Cormorant Global Healthcare Master Fund, LP(0.00%),Cormorant Global Healthcare GP, LLC(0.00%)等

02/14 15:04 (美東)

89bio | SC 13G/A：超過5%持股股東披露文件(修正)-Deep Track Capital, LP(2.10%),Deep Track Biotechnology Master Fund, Ltd.(2.10%)等

02/14 11:37 (美東)

89bio | SC 13G/A：超過5%持股股東披露文件(修正)-BVF Partners L.P.(7.8%),BVF Inc.(7.8%)等

02/14 10:02 (美東)

89bio | SC 13G：超過5%持股股東披露文件-RTW Investments, LP(6.0%),Roderick Wong, M.D.(6.0%)

02/14 07:12 (美東)

89bio | 4：持股變動聲明-高管 Martins Ryan

02/13 21:16 (美東)

89bio | 4：持股變動聲明-高管 Mansbach Harry H

02/13 21:06 (美東)

89bio | 4：持股變動聲明-高管 Le-Nguyen Quoc

02/13 21:06 (美東)

89bio | 4：持股變動聲明-高管 PALEKAR ROHAN

02/13 21:01 (美東)

89bio | SC 13G/A：超過5%持股股東披露文件(修正)-Suvretta Capital Management, LLC(5.2%),Aaron Cowen(5.2%)等

02/13 12:30 (美東)